26th May 2022 | Pharma Updates
Pfizer provide low-cost medicines and vaccines to developing countries
Pfizer announced that it will donate over two dozen medications to some of the world’s poorest countries, including its best-selling COVID-19 vaccines and therapy.
Novartis largest base outside of its headquarters is in Hyderabad
Novartis, a Swiss pharma firm that has been rapidly expanding its presence in Hyderabad, has now grown to over 9,000 people in the city, making it Novartis’ second largest base globally after its headquarters in Basel.
To reduce expenses, the government may 'rationalise' drug trading margins
The government is planning to use the trade margin rationalisation (TMR) formula to lower medicine prices. Last week, the National Pharmaceutical Pricing Authority (NPPA) met with stakeholders to discuss the matter.
Moderna experimenting with potential monkeypox vaccines
As more cases of monkeypox are recorded around the world, Moderna Inc has announced that they are exploring possible vaccines against monkeypox in pre-clinical trials.
Thyrocare opens its first regional processing lab in Nagpur
On the occasion of World Thyroid Day, Thyrocare opened its first Regional Processing Lab (RPL) in Nagpur, making it the 17th lab in India. The centre is located near Mytri Willows, Sir Bezonji Mehta Road, Nagpur.
USFDA refused to approve Verrica's viral skin disease treatment
U.S. Food and Drug Administration has denied to approve Verrica Pharmaceuticals Inc’s (VRCA.O) drug for the treatment of molluscum contagiosum, a viral skin disease.
Patent infringement lawsuits filed by J&J and Momenta Pharma against Natco and Mylan
Johnson & Johnson and Momenta Pharmaceuticals have launched a patent infringement case against Natco and its marketing partner Mylan Pharmaceuticals Inc, among others, in the United States.